• Medication Review Video Module: What is Resmetirom and how does it work to treat MASH?

  • Oct 3 2024
  • Duración: 3 m
  • Podcast

Medication Review Video Module: What is Resmetirom and how does it work to treat MASH?

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Thank you to Madrigal for sponsoring the Medication Review Video Module.

    In this GHAPP Medication Review video, Robin Soto, a board-certified nurse practitioner at UC San Diego Health Hepatology, explains the mechanism of action of Resmetirom, the first and only FDA-approved drug for the treatment of MASH in adults with mild to moderate fibrosis (F2-F3). Robin describes how Resmetirom, a liver-directed, thyroid hormone receptor beta agonist, targets liver fat accumulation, promoting fatty acid oxidation and improving cholesterol metabolism. She highlights its anti-inflammatory effects and ability to reduce liver fibrosis by selectively activating receptors in the liver, while minimizing systemic side effects. For more information, visit the GHAPP website and ACE app.
    Más Menos
activate_Holiday_promo_in_buybox_DT_T2
Más Menos

Lo que los oyentes dicen sobre Medication Review Video Module: What is Resmetirom and how does it work to treat MASH?

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles